Viewpoint Molecular Targeting, Inc. — Form D/A
Viewpoint Molecular Targeting, Inc. of CORALVILLE, IA, a company, filed a Form D amendment with the SEC on 2021-01-15. The offering totals $15.8M, of which $14.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-01-15
- Form: D/A
- Accession: 0001768245-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $15.8M
- Amount sold: $14.3M
- Remaining: $1.6M
- Minimum investment: $25K
- Investors: 29
- Date of first sale: 2020-11-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-382294
Issuer
- Name: Viewpoint Molecular Targeting, Inc.
- CIK: 0001768245
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 2500 CROSSPARK ROAD E-116, CORALVILLE, IA, 52241
- Phone: 8653561861
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Heyward Coleman | Director | Coralville, IA |
| Cameron Gray | Director | Miami, FL |
| Frances Johnson | Director | Coralville, IA |
| Curtis Nelson | Director | Coralville, IA |
| Michael Schultz | Director | LEWES, DE |
| Heyward Coleman | Executive Officer | Coralville, IA |
| Frances Johnson | Executive Officer | Coralville, IA |
| Michael Schultz | Executive Officer | LEWES, DE |
Other filings by this issuer (4)
More